Wendi V. Rodrigueza
No más puestos en curso
Perfil
Wendi V.
Rodrigueza served as Director of Product Development at Esperion Therapeutics, Inc. and Director of Product Management at Novartis Institutes for Biomedical Research, Inc. She was also an Independent Director at Pacific Therapeutics Ltd.
from 2009 to 2015 and Senior Manager of Project Management at CuraGen Corp.
In 2014 to 2016, she served as Chief Scientific Officer at Sierra Oncology, Inc. Rodrigueza earned her undergraduate degree in 1988 and her doctorate in 1994 from the University of British Columbia.
Antiguos cargos conocidos de Wendi V. Rodrigueza.
Empresas | Cargo | Fin |
---|---|---|
SIERRA ONCOLOGY, INC. | Director Técnico/Científico/I+D | 25/02/2016 |
Pacific Therapeutics Ltd.
Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | 25/08/2015 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Wendi V. Rodrigueza.
University of British Columbia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ESPERION THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Pacific Therapeutics Ltd.
Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Wendi V. Rodrigueza